Preparation and MRI Study of HER2-Targeted Bimodal Molecular Probe Gd-Cy5.5-Pertuzumab for Thyroid Cancer

<div>Gd-Cy5.5-pertuzumab, Gd-DOTA-pertuzumab, Gd-DTPA relaxation rate.</div>

Contrast Media & Molecular Imaging

Figure 4: Preparation and MRI Study of HER2-Targeted Bimodal Molecular Probe Gd-Cy5.5-Pertuzumab for Thyroid Cancer 